Inactive

SUBJECT: Combined Synopsis/Solicitation for; MEDRAD Mark 7 Arterion Injection System 1.) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance ... SUBJECT: Combined Synopsis/Solicitation for; MEDRAD Mark 7 Arterion Injection System 1.) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. 2.) The Solicitation ID for this requirement is 0011825553-0001, This Requirement is being solicited as a Request for Quotes (RFQ). 3.) This solicitation document incorporates provisions and clauses from Federal Acquisition Regulation (FAR), FAC 2202-07; and supplemental Regulations from the Defense Federal Acquisition Regulation Supplement (DFARS), DFARS Change 6/23/2022. 4.) This requirement is being solicited as a Sole Source Requirement under a brand Name description, and as such will not be considered for small-business set-aside. 5.) The table below provides the itemized list of materials required for this requirements, interested parties are shall fill the table with applicable information as it pertains to this requirement; i.e Unit price, extended price, estimated delivery, etc. 6.) Offers are due 8 September 2022, by 1300 EST. 7.) The provision 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services, applies to this acquisition 8.) The provision 52.212-2, Evaluation-Commercial Products and Commercial Services is incorporated in this requirement as prescribed IAW FAR 12.301(C). The government will award a contract resulting from this solicitation to the offeror whose offer conforming to the Solicitation will be most advantageous to the government. The government will evaluate quotes based on price, technical acceptability, and conformity to the solicitation. 9.) Potential offerors must provide a complete copy of the provision 52.213-3, Offeror Representations and Certifications-Commercial Products and Commercial Services, with their offer. 10.) The Clause 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services, applies to this acquisition. 11.) The Clause 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services, applies to this acquisition. 12.) The Primary POC for this requirement is Contract Specialist, Matthew Shozo Tsueda; Phone 907-201-0308; Email: Matthew.S.Tsueda.Ctr@Health.Mil